Warning letter cloud clears for Cordis
This article was originally published in Clinica
Executive Summary
Cordis is pushing ahead with US trials of its next-generation Cypher drug-eluting stent (DES), after having successfully resolved the issues contained in a warning letter issued by the FDA in 2004.